Miley Cyrus Recovering After Hospitalization

Miley Cyrus is back on the road. Well, not exactly, but she is on the road to recovery. Early in April, Cyrus had to be hospitalized after suffering from a severe allergic reaction to Penicillin. Mile...
Miley Cyrus Recovering After Hospitalization
Written by

Miley Cyrus is back on the road. Well, not exactly, but she is on the road to recovery.

Early in April, Cyrus had to be hospitalized after suffering from a severe allergic reaction to Penicillin. Miley had been battling a sinus infection when she was prescribed the drug Cephalexin. Cephalexin is in the same drug class as Penicillin, and caused the 21-year-old to have the reaction.

During a recent interview with Ryan Seacrest on his radio show On Air with Ryan Seacrest, Miley opened up about her scary hospital stay and having to postpone her Bangerz tour.

“They gave me this medicine and I was on this medicine for five days. It’s all good and then on the sixth day I just woke up and it was … so scary. I had basically been poisoning myself with something I didn’t know I was really scary allergic to,” Miley explained to Ryan. “I never thought I’d get stuck in there as long as I did. I basically thought I’d be stuck for a night, and I was actually there for five or six days.”

Miley revealed that the worst part of her hospital stay was not being out on the road. “Honestly just not being out on the road,” she said. “I would feel good … [and ask doctors] ‘Can I go? Can I get back on the stage?’ That was the hardest part. … I was just crying because I was so bored.”

Miley will kick off the European leg of her Bangerz tour on Friday. Her first stop will be in Amsterdam. “I should be all good, but what was the worst is that this reaction can happen from five to 27 days,” she explained. “But I’ve been really good, and now, I just have to be more careful.”

Miley also tweeted the rescheduled Bangerz dates for the US.

Image via Twitter

Get the WebProNews newsletter delivered to your inbox

Get the free daily newsletter read by decision makers

Subscribe
Advertise with Us

Ready to get started?

Get our media kit

Advertise with Us